<?xml version="1.0" encoding="UTF-8"?>
<p>SwissADME webserver (
 <ext-link ext-link-type="uri" xlink:href="http://www.swissadme.ch/" xmlns:xlink="http://www.w3.org/1999/xlink">http://www.swissadme.ch/</ext-link>)
 <xref rid="CIT0053" ref-type="bibr">
  <sup>53</sup>
 </xref> was used to predict the physicochemical characters related to pharmacokinetic parameters of the new compounds. The study was performed following the previous report
 <xref rid="CIT0039" ref-type="bibr">
  <sup>39</sup>
 </xref>. The molecular weights, ClogP, number of hydrogen bond donner (HBD), and hydrogen bond acceptor (HBA) of the new compounds were calculated checked for any violation from Lipinskiâ€™s rule
 <xref rid="CIT0054" ref-type="bibr">
  <sup>54</sup>
 </xref>. The chemical structures were sketched and calculation start following submission of the chemical structures. MVs, TPSA, and DLSs were calculated using Molsoft webserver (
 <ext-link ext-link-type="uri" xlink:href="http://molsoft.com/mprop/" xmlns:xlink="http://www.w3.org/1999/xlink">http://molsoft.com/mprop/</ext-link>). The expected GIT absorption percent (
 <bold>%</bold>Abs) of the new compounds was also calculated according to the previous report
 <xref rid="CIT0055" ref-type="bibr">
  <sup>55</sup>
 </xref>.
</p>
